BioMarin Pharmaceutical Competitors and Similar CompaniesClear all

BioMarin Pharmaceutical's competitors and similar companies include UCB.
BioMarin Pharmaceutical
BioMarin Pharmaceutical
BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
UCB
UCB
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date
Founding Date
1997
Founding Date
1928
Type
Type
Public
Type
Public
Tags
Locations
Locations
San Rafael, US HQ
Martínez, AR
Crows Nest, AU
Sao Paulo, BR
Bogotá, CO
Kronberg Im Taunus, DE
Wanchai, HK
see more
Locations
Brussels, BE HQ
Melbourne, AU
Vienna, AT
Braine L'alleud, BE
Braine L'alleud, BE
Leuven, BE
São Paulo, BR
see more
Employees
Employees
3,0015% increase
Employees
9,052
Valuation ($)
Valuation ($)
13.3 b
Valuation ($)
34.3 b

Financial

Revenue (est.)
Revenue (est.)
$3.2b (FY, 2025)
Revenue (est.)
€7.4b (FY, 2025)
Cost of goods
Cost of goods
$717.4m (FY, 2025)
Cost of goods
€1.4b (FY, 2025)
Gross profit
Gross profit
$2.5b (FY, 2025)
Gross profit
€7.2b (FY, 2025)
Net income
Net income
$348.9m (FY, 2025)
Net income
€1.6b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

UCB
HQ
Brussels, BE
Employees
9,052

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

View company